Table 2.
Summary of discussed comparative studies of HZ/host interactions
| Reference | HZ preparation method | Concentration | Reason for concentration | Cell/model | Major findings relevant to this review |
|---|---|---|---|---|---|
| [13] | nHZ: In Table 1 | 115 μg nHZ/well Corresponding to 30 nmol heme/well 50,000 monocytes/well |
Not specified | Human PBMC |
|
| [15] | nHZ: In Table 1 | 100 fmol heme/monocyte Corresponding to 50 RBC/monocyte |
Not specified | Human PBMC | nHZ induced production of esterified monohydroxy derivatives of polyenoic acids in a complex isomeric pattern, suggesting nonenzymatic oxidation |
| [17] | sHZ: [43] nHZ: In Table 1 |
10–50 μg/mL | Not specified | Murine MΦ cell line B10R | nHZ and sHZ alone did not lead to NO generation, while the presence of IFN-γ led to inducible nitrate oxide synthase and NO production |
| [16] | sHZ: [43] nHZ: In Table 1 |
10–75 μg/mL | Specified | Murine MΦ cell line B10R | nHZ and sHZ induced ROS generation, predominantly superoxide anion, and chemokines |
| [9] | sHZ: [43] nHZ: In Table 1 |
In vitro: 30 or 100 μM In vivo: 1500 μg HZ |
Specified | Murine Flt3 ligand-induced BMDCs; Wild-type (WT) C57BL/6 or mutant mice (MyD88−/−, TRIF−/−, TLR2−/−, TLR4−/−, TLR7−/−, and TLR9−/−) |
|
| [8] | sHZ: [43] nHZ: In Table 1 |
50 ^M nHZ 150 ^M sHZ | Not specified | Murine Flt3 ligand-induced BMDC | - Crude bovine sHZ but not pure sHZ induced TNF-α secretion - DNase and nuclease treatment abolished previously observed immune effects, suggesting DNA, not HZ, mediated effects |
| [18] | DV: In Table 1 | 5 ×109 DVs | Not specified | Male Sprague-Dawley outbred rats |
|
| [19] | DV: In Table 1 | Phagocytosis: 3–5 DVs/neutrophil ROS generation and bacterial killing assay. 2–3 DVs/5 neutrophils | Not specified | Healthy human neutrophils, in some experiments + Staphylococcus aureus |
|
| [20] | sHZ: [12] nHZ: In Table 1 |
100 fmol heme/monocyte Corresponding to 50 RBC/monocyte |
Not specified | Human PBMC |
|
| [23] | sHZ: [12] nHZ: In Table 1 |
10 μg/mL | Specified | Primary human ST | nHZ, but not sHZ, increased ERK1/2 phosphorylation, chemokine, and cytokine secretion, increased ICAM-1 expression, and monocyte migration |
| [26] | nHZ: In Table 1 | 25–100 μM | Specified | WT C57/B6 BDMCs |
|
| [61] | sHZ: [12, 75] | 0.5, 0.8, 2.5, 4.0, 10, 12.5 and 20 nmol/mL | Specified | Human fetal neurons and astrocytes | Astrocytes and neurons phagocytosed nHZ and exhibited signs of apoptosis |
| [62] | sHZ: purchased from InvivoGen | 200 and 400 μg/mL | Not specified | BV-2 murine microglial cell line ReNcell VM cell line | sHZ caused significant increases in proinflammatory cytokines, caspase activity, NF-κB and NLRP3 pathway activity, microglial-induced neurotoxicity, and direct neurotoxicity |
| [29•] | DV: In Table 1 | Not specified | Not specified | Human neutrophils | NETosis is stimulated by heme but not DVs |
| [10••] | sHZ purchased from InvivoGen |
ROS: 100 μg/ml DC-T cell coculture assay: 100, 50, 20 μg/ml |
Not specified | CLEC12A−/− and WT C57/B6 BDMCs; CLEC12A−/− and WT C57L/B6 mice; CD8+ T cells from OT-I transgenic mice |
|
| [77] | sHZ purchased from InvivoGen | 50 and 100 ug/mL | Not specified | Human neutrophils |
|
| [30••] | nHZ: In Table 1 | In vitro: P. yoelii nHZ, 30 ug/mL In vivo: P. yoelii nHZ, 1 mg, P. falciparum nHZ, 1–1.5 mg |
Not specified | In vitro: Murine splenic phagocytes + L. monocytogenes In vivo: Mice treated with Py nHZ then orally challenged with L. monocytogenes after 7 days; mice treated with Pf nHZ then intranasally challenged with S. pneumoniae after 7 days |
|